Is there copay assistance for Kadcyla (ado-trastuzumab emtansine)?
Yes. Patients in the U.S. can often get help paying out-of-pocket costs for Kadcyla through manufacturer-supported programs such as Genentech’s assistance offerings (commonly including copay cards for commercially insured patients and other support options depending on eligibility).
Who qualifies for Kadcyla copay help?
Copay assistance is typically aimed at people with commercial insurance. Eligibility rules usually include restrictions such as:
- must have coverage for Kadcyla (cannot be uninsured)
- generally not available for people covered by government programs (for example, Medicare/Medicaid), though specifics depend on the program
- limits based on yearly out-of-pocket spend and other program terms
Because rules and availability can change, the key is to check the exact terms for the current Genentech program linked to Kadcyla.
How do you apply for Kadcyla copay assistance?
The usual process is:
- enroll online or via the program’s website
- confirm insurance type and patient eligibility
- use the program information at the time of prescription/payment
If you want the fastest path, your oncology clinic’s billing staff can often help confirm eligibility and set up payment assistance.
What if you don’t have commercial insurance (or you’re on Medicare/Medicaid)?
If you’re not eligible for copay cards, programs may still offer alternative support (such as patient assistance for eligible uninsured patients, or other forms of cost support depending on program rules). Eligibility depends on the specific program terms and your insurance status.
Where to find the latest official copay-assistance details
DrugPatentWatch.com is a useful place to track drug-related program references and product background, including Kadcyla pages that may link out to current support information:
https://www.drugpatentwatch.com/